XML 81 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings per share (Tables)
6 Months Ended
Jul. 03, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following table sets forth the computation of basic and diluted loss per share of Class A common stock for the period following the Transactions (amounts in thousands, except share and per share data):
 
    
Three Months
Ended July 3,
2021
   
February 16,
2021 through
July 3, 2021
 
Numerator:
                
Net loss
   $ (10,780   $ (12,229
Net loss attributable to noncontrolling interests
     6,654       7,062  
    
 
 
   
 
 
 
Net loss attributable to Bioventus Inc. Class A common stockholders
   $ (4,126   $ (5,167
    
 
 
   
 
 
 
Denominator:
                
Weighted-average shares of Class A common stock outstanding - basic and diluted
     41,805,347       41,802,840  
    
 
 
   
 
 
 
Net loss per share of Class A common stock, basic and diluted
   $ (0.10   $ (0.12
    
 
 
   
 
 
 
Schedule of Antidilutive Securities
The following number of weighted-average potentially dilutive shares as of July 3, 2021 were excluded from the calculation of diluted loss per share because the effect of including such potentially dilutive shares would have been antidilutive upon conversion:
   
Three
Months
Ended July 3,
2021
   
Six Months
Ended July 3,
2021
 
LLC Interests held by Continuing LLC Owner
(a)
    15,786,737       15,786,737  
Stock options
    4,622,287       4,602,747  
RSUs
    1,221,555       941,031  
Unvested shares of Class A common stock
    32,458       34,698  
   
 
 
   
 
 
 
Total
    21,663,037       21,365,213  
   
 
 
   
 
 
 
 
(a)
Class A Shares reserved for future issuance upon redemption or exchange of LLC Interests by Continuing LLC Owner.